Galderma Group AG (GDERF)
Galderma Group Market Cap: 48.20B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BeOne Medicines Ltd. | 35.71B |
| AC Immune SA | 280.67M |
| CRISPR Therapeutics AG | 5.488B |
| Addex Therapeutics Ltd. | 9.338M |
| NewCelX Ltd. | 1.920M |
Market Cap Related Metrics
| PE Ratio | 129.11 |
| PS Ratio | 10.48 |
| Price to Free Cash Flow | 66.67 |
| Price | 205.25 |
| Earnings Yield | 0.77% |
| Operating PE Ratio | 67.31 |
| Normalized PE Ratio | 116.78 |